CYP2C19 and Alzheimer disease: So, for CYP2D6 UM and CYP2C19 UM (and RM, but without statistical significance = 0.08) the differences can be explained by the history of antidepressant treatment in our cohort: 84 patients were taking an antidepressant on admission (AD-treated group) and prior to PGx testing.